|
| |
Karl
Press Releases on Karl:
|
 |
| Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis |
23rd November, 2009 |
|
NOVATO, California, November 23 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP),
today announced results from a Phase 2b clinical trial of
|
| AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing |
19th November, 2009 |
AFFiRiS AG |
VIENNA, Austria, November 19 /PRNewswire/ -- AFFiRiS AG will focus its
Alzheimer's vaccine program on one product candidate at an unexpectedly early
stage of development: the vaccine
|
| Video: CRESTOR(R) Reduced Risk of Cardiovascular Events in Women by Nearly Half in New Analysis of JUPITER Study |
17th November, 2009 |
AstraZeneca |
-- An analysis of 5,466 patients with impaired fasting glucose (IFG) at
baseline demonstrated that CRESTOR 20 mg significantly reduced the risk
of CV events by 32 percent (p=0.028
|
| Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update |
17th November, 2009 |
Neuralstem, Inc. |
ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today provided a financial and business update for the third quarter ended September 30, 2009.
|
| Nielsen Announces 2009 Winners of the First-Ever CLIO Healthcare Awards |
16th November, 2009 |
The Nielsen Company |
NEW YORK, Nov. 16 /PRNewswire/ -- The Nielsen
|
Karl results (if any) from reagent suppliers | 
|
Monoclonal Antibody to Psoriasin/HID5/S100A7
Richard D. Kennedy, Julia J. Gorski, Jennifer E. Quinn, Gail E. Stewart, Colin R . James, Stephen Moore, Karl Mulligan, Ethan D. Emberley, Tong F. Lioe, ...
http://www.imgenex.com/antibody_details.php?catalog=IMG-409A...
|
 |
BenderMed Systems: Literatur Details - Anti-human CD44std Antibody ...
Van Hal,Nicole L.W.; van Dongen,Guus A.M.S.; Ten Brink,Corlinda B.M.; Heider, Karl Heinz; Rech-Weichselbraun,Irene; Snow,Gordon B.; Brakenhoff,Ruud H. ...
http://www.bendermedsystems.com/products/BMS150&c=1...
|
 |
Monoclonal Antibody to Psoriasin/HID5/S100A7
Colin R. James, Stephen Moore, Karl Mulligan, Ethan D. Emberley, Tong F. Lioe, Patrick J. Morrison, Paul B. Mullan, George Reid, Patrick G. Johnston, ...
http://www.imgenex.com/tds/IMG-409A.pdf...
|
 |
Techinical Support for Sera & Immunoglobulins
... (less than 1% sodium by weight as determined by atomic emission) and contain less than 10% water by weight as determined by the Karl-Fischer method. ...
http://www.sigmaaldrich.com/life-science/cell-biology/antibo...
|
 |
Polyclonal Antibody to DR4/TRAILR1 (CT)
John R. Basile, Valerie Zacny, and Karl Münger. J. Biol. Chem, 276: 22522 22528 (2001). 3. Synergistic antitumor activity of TRAIL combined with ...
http://www.imgenex.com/tds/IMG-108-1.pdf...
|
 |
Protein Array Processing with Unprecedented Sensitivity and Automation
Protein Array Processing with Unprecedented Sensitivity and Automation. Karl Adler, Chris Coniglio, Amy McCann,. PerkinElmer Life and Analytical Sciences,
...
http://las.perkinelmer.com/content/relatedmaterials/posters/...
|
 |
Polyclonal Antibody to DR5/Apo2/TRAIL-R2/TRAILR2/TRICK2/KILLER
John R. Basile, Valerie Zacny, and Karl Münger. J. Biol. Chem, 276: 22522 22528 (2001). 11. Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy ...
http://www.imgenex.com/tds/IMG-120E.pdf...
|
 |
Search Bioportfolio and other Life Science Sites for Karl,
or search for Karl on BioPortfolio's antibody search engine.
This page has been viewed 122 times
Recent Search Terms used to find this page: karl mulligan | praveen gajawada | rech weichselbraun | Praveen Gajawada | Paul Karl Horan | karl horan | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
